Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Daily News

FH Screening Started at Time of Childhood Immunization Feasible and Effective

Michael O'Riordan

October 28, 2016

News Daily News

Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies

Michael O'Riordan

September 27, 2016

News Conference News ESC 2016

Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER

Michael O'Riordan

August 30, 2016

News Daily News

尽管有战乱和冲突，但缺血性心脏病的死亡率仍然迎来了“阿拉伯之春”

Michael O'Riordan

August 26, 2016

News Daily News

Despite War and Strife, Ischemic Heart Disease Leads Deaths in ‘Arab Spring’

Michael O'Riordan

August 26, 2016

News Daily News

Depression Increases Risk of Acute MI by 30% in HIV-Positive Patients

August 25, 2016

News Daily News

Improved Adherence to Medical Therapy Reduces CVD Events in Secondary Prevention Patients

Michael O'Riordan

August 16, 2016

News Daily News

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

Michael H. Wilson

July 13, 2016

News Daily News

Protein-Based Risk Score Shows Potential for Tailored Medicine in Cardiology

Yael L. Maxwell

June 24, 2016

News Daily News

不同收入水平的急性心肌梗死住院率和死亡率有所减少，但差距仍然存在

May 16, 2016

News Daily News

Se Observan Descensos en las Hospitalizaciones por IAM y Mortalidad en Distintos Niveles de Ingresos Aunque se Mantienen las Disparidades

May 16, 2016

News Daily News

Reductions in Acute MI Hospitalization, Mortality Seen Across Income Levels, but Disparities Linger

May 16, 2016

News Daily News

Low BMI in and of Itself Portends Poor Survival After Acute MI

April 21, 2016

News Daily News

在他汀类药物治疗基础上添加依泽替米贝可以降低首次和后续心血管事件的风险：IMPROVE-IT 分析

Michael O'Riordan

January 26, 2016

News Daily News

Análisis del IMPROVE-IT: La Incorporación de Ezetimibe al Tratamiento con Estatinas Reduce el Riesgo de Sufrir Primeros y Subsiguientes Episodios CV

Michael O'Riordan

January 26, 2016

News Daily News

Adding Ezetimibe to Statin Therapy Reduces Risk of First and Subsequent CV Events: IMPROVE-IT Analysis

Michael O'Riordan

January 26, 2016

News Industry News

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

September 08, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Industry News

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

June 09, 2015

News Daily News

MI患者的低试验参与率引起了对适用性的质疑

September 02, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.